Anandita Mitra

Therapeutic targeting of cancer-associated PKM2 mutants by shikonin via mutation-induced pocket recognition.

This study demonstrates that PKM2 mutations dynamically remodel the binding pocket and allosteric communication to facilitate shikonin recognition, highlighting the newly identified pocket as a promising therapeutic site for future PKM2 targeted drug design.